3Llovet JM, Fuster J, Bruix J. The Barcelona approach : di- agnosis,staging, and treatment of hepatocellular carcino- ma[J]. Liver Transpl,2004,10(2 Suppl 1) :S115-S120.
4Beck B,Blanpain C. Unravelling cancer stem cell potential [J]. Nat Rev Cancer,2013,13(10) : 727-738.
5Klein CA. Selection and adaptation during metastatic cancer progression[J]. Nature, 2013,501 (7467) : 365-372.
6Bedard PL, Hansen AR, Ratain MJ, et al. Tumour hetero- geneity in the clinic[J]. Nature, 2013,501 (7467) : 355- 364.
7Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity[J]. Nature, 2013,501 (7467) : 328-337.
8Valent P, Bonnet D, De Maria R, et al. Cancer stem cell definitions and terminology:the devil is in the details[J]. Nat Rev Cancer, 2012,12 ( 11 ) : 767-775.
9Sell S,Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma[J]. Am J Pathol,1989,134(6) :1347-1363.
10Zhang Y, Li J, Cao L, et al. Circulating tumor cells in hep- atocellular carcinoma: detection techniques, clinical impli- cations, and future perspectives[J]. Semin Oncol, 2012,39 (4) :449-460.
